VA launches trial to test GLP-1 medication for alcohol use disorder in veterans
The Department of Veterans Affairs is launching a nationwide clinical trial to determine whether semaglutide, marketed as Ozempic…
Loving your body in a world where weight stigma helps sell GLP-1 drugs
Whether you’re living in a body that’s large or small, the rise of GLP-1 advertising and its use…
Oral Ozempic Cuts Heavy Drinking and Cravings
Summary: In a clinical trial, oral semaglutide was found to significantly reduce heavy drinking days, daily cravings, and…
Which group achieves 41% more weight loss on GLP-1s like Mounjaro
It’s a battle of the sexes. The diabetes-turned-weight-loss drug Mounjaro has been making headlines for its effectiveness at…
‘Super weight loss’ drug retatrutide could be available soon
KENT COUNTY, Mich — A new weight loss drug could soon be joining the growing list of medications…
GLP-1s and vision loss: Risk increase real but negligible
“I would not recommend stopping a GLP-1 medication solely because of this study,” Dave categorically emphasized. “These medications…
TGA issues warning over GLP-1-based drugs’ potential to cause rare eye disorder
The medicines regulator has issued a new safety warning for GLP-1-based drugs, like Ozempic, which could potentially cause…
New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Fat » World Business Outlook
Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, recently announced the publication…
FDA puts pharmacist on notice for selling unapproved weight-loss injections
SAN DIEGO, Calif. — A former Rancho Santa Fe pharmacist has agreed to stop selling unapproved weight-loss injections…
GLP-1 Drugs May Be Quietly Changing How Americans Order Drinks
As GLP-1 use grows, clinical trials suggest semaglutide may reduce alcohol cravings and drinks per occasion, putting greater…
The Great Peptide Cash Grab Has Begun
Has anyone tried to sell you peptides yet? If not, they probably will soon. Once a niche interest…
GLP-1 drugs linked to 17% drop in worker sick leave, new economic study finds
GLP-1 drugs could lead to cost savings for workers and their employers by reducing employee sick leave, a…